Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Mikami

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Seminars in Immunopathology|March 21, 2019
Epigenetic regulation of T helper cells and intestinal pathogenicityYuya Hagihara, Yusuke Yoshimatsu, Yohei Mikami, et al.
Journal of Gastroenterology|March 20, 2026
Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel diseaseHaruka Okada, Shinya Sugimoto, Atsuto Kayashima, et al.
Immunological Medicine|December 22, 2025
Neural regulation of gut inflammation via autonomic nerves: therapeutic implications for inflammatory bowel diseaseMai Hasegawa, Takaaki Kawaguchi, Hiroki Kiyohara, et al.
Cell Stem Cell|December 12, 2018
Human Intestinal Organoids Maintain Self-Renewal Capacity and Cellular Diversity in Niche-Inspired Culture ConditionMasayuki Fujii, Mami Matano, Kohta Toshimitsu, et al.
Biochemical and Biophysical Research Communications|August 22, 2012
IgA plasma cells express the negative regulatory co-stimulatory molecule programmed cell death 1 ligand and have a potential tolerogenic role in the intestineTomomitsu Doi, Takanori Kanai, Yohei Mikami, et al.
Intestinal Research|February 11, 2026
Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficult-to-treat inflammatory bowel disease: a single-center retrospective study in JapanIchiro Mizushima, Yusuke Yoshimatsu, Hiroki Kiyohara, et al.
Inflammatory Intestinal Diseases|December 25, 2025
Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein Levels in Inflammatory Bowel Disease Patients across Racial GroupsYasuhiro Aoki, Hiroki Kiyohara, Shinya Sugimoto, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|February 20, 2025
The gut-organ axis: Clinical aspects and immune mechanismsNaoto Fukasawa, Junya Tsunoda, Shogo Sunaga, et al.
Blood|October 18, 2008
Critical role of class IA PI3K for c-Rel expression in B lymphocytesSatoshi Matsuda, Yohei Mikami, Masashi Ohtani, et al.
European Journal of Immunology|March 11, 2018
NCR<sup>+</sup> ILC3 maintain larger STAT4 reservoir via T-BET to regulate type 1 features upon IL-23 stimulation in miceYohei Mikami, Gianluca Scarno, Beatrice Zitti, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Seminars in Immunopathology|March 21, 2019
Epigenetic regulation of T helper cells and intestinal pathogenicityYuya Hagihara, Yusuke Yoshimatsu, Yohei Mikami, et al.
Journal of Gastroenterology|March 20, 2026
Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel diseaseHaruka Okada, Shinya Sugimoto, Atsuto Kayashima, et al.
Immunological Medicine|December 22, 2025
Neural regulation of gut inflammation via autonomic nerves: therapeutic implications for inflammatory bowel diseaseMai Hasegawa, Takaaki Kawaguchi, Hiroki Kiyohara, et al.
Cell Stem Cell|December 12, 2018
Human Intestinal Organoids Maintain Self-Renewal Capacity and Cellular Diversity in Niche-Inspired Culture ConditionMasayuki Fujii, Mami Matano, Kohta Toshimitsu, et al.
Biochemical and Biophysical Research Communications|August 22, 2012
IgA plasma cells express the negative regulatory co-stimulatory molecule programmed cell death 1 ligand and have a potential tolerogenic role in the intestineTomomitsu Doi, Takanori Kanai, Yohei Mikami, et al.
Intestinal Research|February 11, 2026
Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficult-to-treat inflammatory bowel disease: a single-center retrospective study in JapanIchiro Mizushima, Yusuke Yoshimatsu, Hiroki Kiyohara, et al.
Inflammatory Intestinal Diseases|December 25, 2025
Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein Levels in Inflammatory Bowel Disease Patients across Racial GroupsYasuhiro Aoki, Hiroki Kiyohara, Shinya Sugimoto, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|February 20, 2025
The gut-organ axis: Clinical aspects and immune mechanismsNaoto Fukasawa, Junya Tsunoda, Shogo Sunaga, et al.
Blood|October 18, 2008
Critical role of class IA PI3K for c-Rel expression in B lymphocytesSatoshi Matsuda, Yohei Mikami, Masashi Ohtani, et al.
European Journal of Immunology|March 11, 2018
NCR<sup>+</sup> ILC3 maintain larger STAT4 reservoir via T-BET to regulate type 1 features upon IL-23 stimulation in miceYohei Mikami, Gianluca Scarno, Beatrice Zitti, et al.
Pageof 13